These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1326635)

  • 21. 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.
    Salituro FG; Harrison BL; Baron BM; Nyce PL; Stewart KT; Kehne JH; White HS; McDonald IA
    J Med Chem; 1992 May; 35(10):1791-9. PubMed ID: 1534125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
    J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus.
    Raiteri M; Fontana G; Fedele E
    Eur J Pharmacol; 1990 Aug; 184(2-3):239-50. PubMed ID: 2150375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related changes of strychnine-insensitive glycine receptors in rat brain as studied by in vitro autoradiography.
    Miyoshi R; Kito S; Doudou N; Nomoto T
    Synapse; 1990; 6(4):338-43. PubMed ID: 1962912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontogeny of strychnine-insensitive [3H]glycine binding sites in rat forebrain.
    Shinohara K; Nishikawa T; Yamazaki K; Takahashi K
    Neurosci Lett; 1989 Nov; 105(3):307-11. PubMed ID: 2556666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex.
    Rowley M; Leeson PD; Stevenson GI; Moseley AM; Stansfield I; Sanderson I; Robinson L; Baker R; Kemp JA; Marshall GR
    J Med Chem; 1993 Oct; 36(22):3386-96. PubMed ID: 8230129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New synthesis of substituted 2-carboxyindole derivatives: versatile introduction of a carbamoylethynyl moiety at the C-3 position.
    Hewkin CT; Di Fabio R; Conti N; Cugola A; Gastaldi P; Micheli F; Quaglia AM
    Arch Pharm (Weinheim); 1999 Feb; 332(2):55-8. PubMed ID: 10191715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor.
    Kojima-ishii K; Kure S; Ichinohe A; Shinka T; Narisawa A; Komatsuzaki S; Kanno J; Kamada F; Aoki Y; Yokoyama H; Oda M; Sugawara T; Mizoi K; Nakahara D; Matsubara Y
    Pediatr Res; 2008 Sep; 64(3):228-33. PubMed ID: 18414141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of five glycine site antagonists on NMDA receptor desensitisation.
    Molnár P; Erdõ SL
    Eur J Pharmacol; 1996 Sep; 311(2-3):311-4. PubMed ID: 8891614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel structure having antagonist actions at both the glycine site of the N-methyl-D-aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization.
    Snell LD; Claffey DJ; Ruth JA; Valenzuela CF; Cardoso R; Wang Z; Levinson SR; Sather WA; Williamson AV; Ingersoll NC; Ovchinnikova L; Bhave SV; Hoffman PL; Tabakoff B
    J Pharmacol Exp Ther; 2000 Jan; 292(1):215-27. PubMed ID: 10604951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The glycine site of the N-methyl-D-aspartate receptor channel: differences between the binding of HA-966 and of 7-chlorokynurenic acid.
    Kloog Y; Lamdani-Itkin H; Sokolovsky M
    J Neurochem; 1990 May; 54(5):1576-83. PubMed ID: 1691278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of strychnine-insensitive glycine binding with MK-801 binding in brain synaptic membranes.
    Yoneda Y; Ogita K; Suzuki T
    J Neurochem; 1990 Jul; 55(1):237-44. PubMed ID: 2192015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]D-serine labels strychnine-insensitive glycine recognition sites of rat central nervous system.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Life Sci; 1990; 46(3):155-64. PubMed ID: 2154648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor.
    Moroni F; Alesiani M; Galli A; Mori F; Pecorari R; Carlà V; Cherici G; Pellicciari R
    Eur J Pharmacol; 1991 Jun; 199(2):227-32. PubMed ID: 1720099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel antagonist, phenylbenzene omega-phosphono-alpha-amino acid, for strychnine-sensitive glycine receptors in the rat spinal cord.
    Saitoh T; Ishida M; Maruyama M; Shinozaki H
    Br J Pharmacol; 1994 Sep; 113(1):165-70. PubMed ID: 7812607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of feeding by 7-chlorokynurenic acid, a strychnine-insensitive glycine binding site antagonist.
    Sorrels TL; Bostock E
    Brain Res; 1992 Feb; 572(1-2):265-8. PubMed ID: 1319272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glycine site of the NMDA receptor--five years on.
    Kemp JA; Leeson PD
    Trends Pharmacol Sci; 1993 Jan; 14(1):20-5. PubMed ID: 8382885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis.
    Ishimaru M; Kurumaji A; Toru M
    Biol Psychiatry; 1994 Jan; 35(2):84-95. PubMed ID: 7909453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists.
    Bigge CF
    Biochem Pharmacol; 1993 Apr; 45(8):1547-61. PubMed ID: 7683469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.